Kit-activating mutations in AML: lessons from PU.1-induced murine erythroleukemia.

Abstract excerpt

In concert with its ligand, the stem cell factor (SCF), the receptor tyrosine kinase c-Kit acts as a key signaling molecule for a number of cell types, including hematopoietic stem cells, mast cells, melanocytes and germ cells. Gain-of-function mutations in c-Kit have been described in a number of human cancers, including testicular germinomas, acute myeloid leukemia and gastrointestinal stromal tumors. Yet their...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Codon
• Share to Erythropoietin
• Share to Leukemia, Erythroblastic, Acute